Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRM2.L Regulatory News (RM2)

  • There is currently no data for RM2

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

27 Jan 2014 07:00

RNS Number : 5177Y
RM2 International SA
27 January 2014
 



RM2 International S.A.

 

Director / PDMR Shareholding

 

RM2 International S.A. ("RM2" or the "Company") announces that, on 24 January 2014, it issued a total of 2,316,405 ordinary shares of $0.01 each in the Company (the "New Ordinary Shares") to certain non-executive directors in RM2 as part of equity incentive arrangements.

 

Following the issue of the New Ordinary Shares, the revised shareholdings of the relevant directors of the Company are as follows:

 

Name

No. of New Ordinary Shares Issued

Total No. of Ordinary Shares Held

% of Enlarged Issued Share Capital

Ian Molson

1,323,660

5,775,000

1.81

Sir Stuart Rose

330,915

1,150,000

0.36

Amaury de Seze

330,915

1,150,000

0.36

Paul Walsh

330,915

1,434,091

0.45

 

Application has been made to the London Stock Exchange for the New Ordinary Shares, which will rank pari passu with the Company's existing Ordinary Shares, to be admitted to trading on AIM, and admission is expected to become effective on 31 January 2014.

 

Following admission, the Company will have 318,560,156 Ordinary Shares outstanding. The figure of 318,560,156 common shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change their interest in, the Company under the Financial Services Authority's Disclosure and Transparency Rules.

 

The New Ordinary Shares are subject to the restrictions applicable to Restricted Shares and to the lock-in arrangements detailed in paragraphs 6.2 and 12 (l) (respectively) of Part VII of the Admission Document dated 17 December 2013 . Accordingly, a Director holding Restricted Shares shall not sell, transfer, mortgage, charge, encumber or otherwise dispose of any of his Restricted Shares as long as certain performance conditions are not fully satisfied (the "Performance Conditions"). The Performance Conditions are linked to the volume weighted average quoted price of the Ordinary Shares (the "Average Price") for a consecutive 30 day period (the "Relevant Period"). If the Average Price is 50 per cent. higher than the Placing Price for the Relevant Period, the Performance Condition in respect of one third of the Director's Restricted Shares shall be fulfilled. If the Average Price is 75 per cent. higher than the Placing Price for the Relevant Period, the Performance Condition in respect of a further one third of the Director's Restricted Shares shall be fulfilled. If the Average Price is 100 per cent. higher than the Placing Price for the Relevant Period, the Performance Condition in respect of the final third of the Director's Restricted Shares shall be fulfilled. If any Performance Conditions are not fully satisfied by 19 November 2023, the Director shall transfer any of his remaining Restricted Shares to the Company at a purchase price equal to the nominal value of the Restricted Shares, being US$0.01 each.

 

For further information please contact:

 

RM2 International S.A. 

+44 (0)20 8820 1412

John Walsh, Chief Executive Officer

Ash Mohindra, Chief Financial Officer

Ruari McGirr, Strategic Development and Investor Relations

 

 

 

Cenkos Securities plc

+44 (0)20 7397 8900

Neil McDonald 

Alan Stewart

Beth McKiernan

 

 

 

Citigate Dewe Rogerson

+44 (0)20 7638 9571

Simon Rigby

Kevin Smith

Lindsay Noton

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBRGDBBXDBGSS
Date   Source Headline
1st Jun 20181:13 pmRNSResult of AGM
21st May 20187:00 amRNSLaunch of Open Offer
21st May 20187:00 amRNS2017 Annual Results
1st May 20187:00 amRNSManufacturing operations update
23rd Apr 201812:55 pmRNSIssue of Shares to Directors
19th Apr 20182:05 pmRNSSecond Price Monitoring Extn
19th Apr 20182:00 pmRNSPrice Monitoring Extension
13th Apr 20184:40 pmRNSSecond Price Monitoring Extn
13th Apr 20184:35 pmRNSPrice Monitoring Extension
13th Apr 20181:33 pmRNSResults of EGM and Trading Update
29th Mar 20187:00 amRNSPlacing, Pref. Share Conversion and Notice of EGM
29th Mar 20187:00 amRNSDirectorate Change
29th Mar 20187:00 amRNSDirectorate Change
20th Mar 20184:40 pmRNSSecond Price Monitoring Extn
20th Mar 20184:35 pmRNSPrice Monitoring Extension
9th Mar 20187:00 amRNSFinancial Position and Product Update
12th Feb 20187:00 amRNSFinancial Position Update
19th Jan 20187:00 amRNSFinancial Position Update
13th Dec 201711:00 amRNSPrice Monitoring Extension
1st Dec 20177:00 amRNSUpdate on Trading and Financial Position
1st Nov 20177:00 amRNSChange of Broker
27th Sep 20177:00 amRNSInterim Results
24th Aug 20177:00 amRNSBoard Appointment and Increase in Treasury Shares
3rd Aug 20177:00 amRNSBoard and Management Changes
28th Jul 20172:47 pmRNSResult of AGM
24th Jul 20171:49 pmRNSProposed Equity Offering Update
11th Jul 20178:23 amRNSAward of Restricted Shares and Options
6th Jul 20177:00 amRNSNotice of EGM
30th Jun 20174:10 pmRNSSubscription for Convertible Preferred Shares
30th Jun 20173:42 pmRNSAppointment of CEO
30th Jun 20173:41 pmRNSAnnual Results 2016
9th Mar 20178:00 amRNSRM2 Wins First Place for IoT Award for Innovation
20th Feb 201710:22 amRNSEGM Resolutions Passed
20th Feb 20177:00 amRNSDirector/PDMR Shareholding
15th Feb 20178:22 amRNSAT&T LTE-M network deployment
6th Feb 20177:00 amRNSNotice of EGM
2nd Feb 20177:00 amRNSRM2 Product Approved by Major US Retailer
22nd Dec 20167:00 amRNSManufacturing operations update
4th Nov 201610:46 amRNSRM2 to Participate in the AT&T
4th Nov 20168:53 amRNSAgreement with Pactiv LLC
2nd Nov 20167:00 amRNSAgreement with Pactiv LLC
1st Nov 20167:00 amRNSPallet Loss Will Be Reduced with RM2 Innovation
20th Oct 20168:25 amRNSNominated Adviser & Joint Broker Appointments
13th Oct 20167:00 amRNSSignificant new agreement
28th Sep 20167:00 amRNSInterim Results
26th Sep 20167:00 amRNSRe Agreement
1st Aug 20162:14 pmRNSIssuance of Convertible Preferred Shares - Amended
29th Jul 20161:36 pmRNSIssuance of Convertible Preferred Shares
22nd Jul 20164:19 pmRNSEGM Resolutions Passed
18th Jul 201610:38 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.